Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01602081 · ClinicalTrials.gov registry record
Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula
A clinical trial, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- 28
- Enrollment target
NCT01602081 is a clinical trial that has completed, run by Cook Group Incorporated. The registered enrollment target is 28 participants.
The verdict
NCT01602081 has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The LIFT+Biodesign® study is a post-market observational study to evaluate the rate of fistula closure in patients with persistent trans-sphincteric anal fistula who receive the Biodesign® Tissue graft as part of their LIFT procedure.
Interventions
- DEVICE reinforce soft tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01602081
The ClinicalTrials.gov registry entry for NCT01602081 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which reinforce soft tissue is the first listed.
NCT01602081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01602081 about?
NCT01602081 is a clinical study titled "Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula". The LIFT+Biodesign® study is a post-market observational study to evaluate the rate of fistula closure in patients with persistent trans-sphincteric anal fistula who receive the Biodesign® Tissue graft as part of their LIFT procedure.
What is the current status of trial NCT01602081?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2013-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01602081?
The interventions under investigation include: reinforce soft tissue (DEVICE).
Who is sponsoring clinical trial NCT01602081?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.